- Home
- TX vs AXSM Comparison
TX vs AXSM Comparison
Compare TX & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TX | AXSM |
|---|---|---|
| Founded | 1961 | 2012 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 9.0B |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TX | AXSM |
|---|---|---|
| Price | $37.96 | $158.93 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 17 |
| Target Price | $36.92 | ★ $209.18 |
| AVG Volume (30 Days) | 168.1K | ★ 504.5K |
| Earning Date | 04-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.13% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.25 | $58.34 |
| Revenue Next Year | $6.86 | $54.30 |
| P/E Ratio | $20.15 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $24.00 | $86.99 |
| 52 Week High | $45.57 | $191.50 |
Technical Indicators
Market Signals| Indicator | TX | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 29.78 | 39.79 |
| Support Level | $37.08 | $153.37 |
| Resistance Level | $38.99 | $169.11 |
| Average True Range (ATR) | 1.14 | 3.97 |
| MACD | -0.35 | -0.23 |
| Stochastic Oscillator | 12.44 | 35.14 |
Price Performance
Historical ComparisonAbout TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.